Group One Trading
PRME icon

Group One Trading’s Prime Medicine PRME Stock Holding History

Group One Trading’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$586K Buy
168,500
+13,800
+9% +$52.5K ﹤0.01% 3196
2025
Q4 		$537K Sell
154,700
-20,200
-12% -$89.9K ﹤0.01% 3429
2025
Q3 		$969K Sell
174,900
-177,200
-50% -$720K ﹤0.01% 3066
2025
Q2 		$870K Buy
352,100
+322,500
+1,090% +$497K ﹤0.01% 2900
2025
Q1 		$58.9K Buy
29,600
+25,600
+640% +$65.3K ﹤0.01% 5030
2024
Q4 		$11.7K Sell
4,000
-226,800
-98% -$796K ﹤0.01% 6022
2024
Q3 		$893K Buy
230,800
+229,800
+22,980% +$1.06M ﹤0.01% 2397
2024
Q2 		$5.14K Buy
1,000
+900
+900% +$5.46K ﹤0.01% 5942
2024
Q1 		$700 Sell
100
-100
-50% -$758 ﹤0.01% 6696
2023
Q4 		$1.77K Buy
+200
New +$1.54K ﹤0.01% 6857

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Group One Trading's PRME Position: Q1 2026 in Review

Group One Trading reduced its Prime Medicine (PRME) stake by 76% in Q1 2026, selling an estimated $299K and leaving 24,766 shares worth $86.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4861.

Group One Trading first reported a position in PRME in Q2 2024 and has held it in 3 quarters since. The position peaked at $358K in Q4 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Group One Trading held 24,766 shares of Prime Medicine worth $86.2K as of Q1 2026.
  • Group One Trading sold 78,447 Prime Medicine shares in Q1 2026, an estimated $299K.
  • Prime Medicine made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4861 holding.
  • Group One Trading first reported a position in Prime Medicine in Q2 2024 and has held it in 3 quarters since.
  • Group One Trading's Prime Medicine position peaked at $358K in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.